Status:
ACTIVE_NOT_RECRUITING
A New Scoring System for Perineural and Vascular Invasion in Pancreatic Cancer
Lead Sponsor:
Massimo Falconi
Conditions:
Pancreas Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to validate both retrospectively and prospectively a newly proposed scoring system for perineural and vascular invasion in pancreatic ductal cancer and correlate it with disea...
Detailed Description
Perineural invasion (PNI) is defined as the presence of cancer cells along nerves and/or within the epineural, perineural and endoneural spaces of the neuronal sheath.Clinically, PNI is associated wit...
Eligibility Criteria
Inclusion
- Patients older than 18 years
- Patients undergoing all types of pancreatic resection (pancreatoduodenectomy, left pancreatectomy, total pancreatectomy, both laparotomic and laparoscopic).
- Proven pancreatic ductal adenocarcinoma (cytology or biopsy).
- Patients that received neoadjuvant therapy (CT +/- RT) can be included.
- Patients able to sign the informed consent.
Exclusion
- Age \< 18 years.
- Patients with other ongoing oncological diseases.
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04024358
Start Date
January 1 2015
End Date
January 1 2025
Last Update
March 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele
Milan, Italy, 20132